Bactericidal/permeability-increasing protein

Bactericidal/permeability-increasing protein (BPI) is a 456-residue (~50kDa) protein that is part of the innate immune system.[1] It belongs to family of lipid-binding serum glycoproteins.

bactericidal/permeability-increasing protein
Identifiers
SymbolBPI
NCBI gene671
HGNC1095
OMIM109195
RefSeqNM_001725
UniProtP17213
Other data
LocusChr. 20 q11.23

Distribution and function

BPI was initially identified in neutrophils, but is found in other tissues including the epithelial lining of mucous membranes.[2] It is an endogenous antibiotic protein with potent killing activity against Gram-negative bacteria. It binds to compounds called lipopolysaccharides produced by Gram-negative bacteria. Lipolysaccharides are potent activators of the immune system; however, BPI at certain concentrations can prevent this activation.

BPI was discovered by Jerrold Weiss and Peter Elsbach at New York University Medical School.

rBPI21

Because lipopolysaccharides are potent inflammatory agents, and the action of antibiotics can result in the release of these compounds, the binding capacity of BPI was explored as a possible means of reducing injury. Xoma Ltd. developed a recombinant 21kDa portion of the BPI molecule called rBPI21, NEUPREX, or opebecan. In a trial, it was found to decrease the mortality of Gram-negative bacterial-induced sepsis.[3] Studies suggest that its binding activity is not the means by which it mediates its protective effect.[4] Studies show biological effects with Gram-positive bacteria[5] and even in infection by the protozoan, Toxoplasma gondii.[6]

gollark: You mean faster as in latency or boot time or what?
gollark: Calculators are a vaguely weird and annoying product because they're very expensive, worse than equivalent general-purpose computing things like phones, and basically *only* exist for exams.
gollark: It always annoys me that foolish human brains are really bad at running things like high-quality RNGs or cryptography.
gollark: Weird. I would have said it was a marker for the heads of something, but I doubt it would have to be dots for that.
gollark: People sometimes say that they can't learn properly without experiencing the real world or whatever, but text is very information-dense and there is a *lot* of it.

References
  1. Elsbach P (July 1998). "The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense". Journal of Leukocyte Biology. Wiley-Liss. 64 (1): 14–8. doi:10.1002/jlb.64.1.14. PMID 9665269. Archived from the original (pdf) on 2008-06-03. Retrieved 2008-04-08.
  2. Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (March 2002). "Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia". Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences. 99 (6): 3902–7. doi:10.1073/pnas.052533799. PMC 122621. PMID 11891303.
  3. Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (September 2000). "Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group". Lancet. Lancet Publishing Group. 356 (9234): 961–7. doi:10.1016/S0140-6736(00)02712-4. PMID 11041396. Lay summary – Business Wire (2000-09-14).
  4. Schlag G, Redl H, Davies J, Scannon P (February 1999). "Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties". Annals of Surgery. Lippincott Williams & Wilkins. 229 (2): 262–71. doi:10.1097/00000658-199902000-00015. PMC 1191640. PMID 10024109.
  5. Srivastava A, Casey H, Johnson N, Levy O, Malley R (January 2007). "Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease". Infection and Immunity. American Society for Microbiology. 75 (1): 342–9. doi:10.1128/IAI.01089-06. PMC 1828387. PMID 17101667.
  6. Khan AA, Lambert LH, Remington JS, Araujo FG (April 1999). "Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii". Antimicrobial Agents and Chemotherapy. American Society for Microbiology. 43 (4): 758–62. doi:10.1128/aac.43.4.758. PMC 89203. PMID 10103177.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.